Effect of Vortioxetine on Maximal electroshock (MES) induced seizures in Sprague Dawley rats-Reference-Cited by-同舟云学术

Effect of Vortioxetine on Maximal electroshock (MES) induced seizures in Sprague Dawley rats

Published:2021-08-06 Issue: Volume: Page:4337-4340
ISSN:0974-360X
Container-title:Research Journal of Pharmacy and Technology
language:en
Short-container-title:RJPT

Author:

Kumar C Sharath¹,Patil Navin²,Parida Amrita¹,Kabirdev Kabirdev¹,Priyadarshini Prachi¹,Gurung Shanti²,Rao N Karthik³,V Manju⁴

Affiliation:

1. Department of Pharmacology, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal - 576104, Karnataka, India.

2. Department of Pharmacology, UCMS, Bhairahawa, Rupandehi, Nepal.

3. Department of Medicine, KS Hegde Medical Academy, Mangaluru.

4. Department of Paediatrics, Melaka-Manipal Medical College, Manipal Campus, Manipal Academy of Higher Education, Manipal, Karnataka, India – 576104.

Abstract

Aim: To investigate the antiepileptic activity of vortioxetine. Materials and method: Vortioxetine was screened for its antiepileptic activity in Sprague-Dawley rats using maximal electroshock model. 4 groups of rats (each 6 rats) were used. First group was administered distilled water, second group diazepam and the third and fourth groups were given vortioxetine 10mg/kg and 20mg/kg respectively. These drug were given 30 minutes before the animal was subjected to electroshock (150mA, 50Hz for 0.2 seconds). Results: Vortioxetine effectively reduced tonic hind limb extension (THLE) in the rats and the effect was statistically significant compared to the control group. The seizure duration was also significantly lower compared to the control. There was no substantial difference in the duration of seizures and THLE between the diazepam and vortioxetine group. However, the total seizure score of the vortioxetine group was not statistically significant compared to the control group. Conclusion: Vortioxetine has the potential to be clinically useful in treating epilepsy. Further detailed studies using other animal models and in humans are required to prove its efficacy in epilepsy.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference22 articles.

1. Smith MD, Metcalf CS, and Wilcox KS. Pharmacotherapy of the Epilepsies. In: Bruton LL, Hilal-Dandan R, Knollmann BC, editors. Goodman and Gilman’s The pharmacological basis of therapeutics. 13th ed. New York: The McGraw-Hill Companies, Inc.; 2018. p. 303.

2. Tripathi KD. Antiepileptic drugs. In: Essentials of medical pharmacology. 7th ed. New Delhi: Jaypee brothers medical publishers (p) ltd; 2015.p. 411-24.

3. Ogun MN, Cetinkaya A, Beyazcicek E. The effect of vortioxetine on penicillin-induced epileptiform activity in rats. Arq Neuropsiquiatr. 2019; 77(6): 412-17.

4. Kanner AM. Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence. Epilepsy Behav. 2016; 61: 282-86.

5. D'Agostino A, English CD, Rey JA. Vortioxetine (brintellix): a new serotonergic antidepressant. P T. 2015; 40(1): 36-40.